Agilent Technologies (A) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Agilent Technologies (A)

A 143.96

+0.5%

2:39 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: JakeStraw	3/24/2017 8:32:12 AM
	Read Replies (1) of 620

n an uncertain health care market, one biotechnology player stands out to Jim Cramer as a "rare island of calm" that is shaping up to be a prime takeover target: Agilent. With low debt, lots of cash on hand, strong fundamentals, and plenty of overseas exposure, the "Mad Money" host said Agilent has "exactly the kind of profile investment bankers look for when they pitch potential takeover targets to their clients." But who would acquire the high-tech medical measurements maker? "I can think of one potential suitor that would be a perfect fit," Cramer said. "General Electric." The multinational's life sciences division makes similar products to Agilent, and if GE wanted to expand into health care, Agilent represents a near-bottom buy despite its dramatic upward move. "I think the stock either goes higher thanks to its strong fundamentals, or it spikes on a takeover bid from someone like GE," Cramer predicted. cnbc.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next